XYLOCOR THERAPEUTICS, INC. — Form D
XYLOCOR THERAPEUTICS, INC. of Malvern, PA, a company, filed a Form D exempt-offering notice with the SEC on 2017-12-06. The offering totals $100K, of which $100K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2017-12-06
- Form: D
- Accession: 0001690467-17-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $100K
- Amount sold: $100K
- Investors: 1
- Date of first sale: 2017-11-27
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-300173
Issuer
- Name: XYLOCOR THERAPEUTICS, INC.
- CIK: 0001690467
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2013
- Address: 39 Addison Lane, Malvern, PA, 19355
- Phone: 888-290-0081
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| Glenn Batchelder | Director | Corcord, NH |
| Fouad Azzam, Ph.D. | Director | Malvern, PA |
| Aidan F King | Director | Malvern, PA |
| Michael F Powell, Ph.D. | Director | Malvern, PA |
| Todd K Rosengart, M.D. | Director | Malvern, PA |
| Albert Gianchetti | Director | Malvern, PA |
| Albert Gianchetti | Executive Officer | Malvern, PA |
| Todd Rosengart | Director | Malvern, PA |
| James Cohen | Director | Malvern, PA |
Other filings by this issuer (5)
More